Day: August 7, 2020

Investor Webinar to be held Monday, August 10th at 10 am Eastern TimeNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Social-impact investment company QuestCap Inc.  (CSE:QSC; FRA:34C1) is pleased to host a corporate webinar to provide updates and developments from investment partners.QuestCap’s recent investments include:Glenco Medical Corp. is a medical treatment company that specializes in extended clinical care, home treatment and innovative performance technologies using wearable, unrestricted and individual therapies to accelerate orthopaedic injury healing and training recovery. Glenco Medical develops and organizes data driven COVID-19 screening protocols and testing procedures. As virus testing is crucial for recovery, these protocols...

SAN DIEGO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leading National Security Solutions provider, today announced that its President & CEO, Eric DeMarco, and its Executive VP & CFO, Deanna Lund, will present at the Canaccord Virtual Conference on August 13th at 1:00pm Eastern.A live webcast of Kratos’ presentation will be available on the Company’s website at https://ir.kratosdefense.com/events-presentations. The webcast will be archived on the Company’s website for 90 days following the event.About Kratos Defense & Security SolutionsKratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises....

HRC WORLD PLCNASDAQ FIRST NORTH GROWTH MARKET, COPENHAGENTICKER: HRCISIN: GB00BZ3CDY207 AUGUST 2020APPOINTMENT OF DIRECTORAPPOINTMENT OF DR. KHUSSAIRIEE AHMAD AS NON-EXECUTIVE DIRECTOR ANDREDESIGNATION OF SHAILEN GAJERA AS CHAIRMANHRC World Plc (the Company), is glad to announce that it has appointed Dr. Khussairiee Ahmad as a Non-Executive Director with immediate effect. Simultaneously, Shailen Gajera, a member of the board, will be become Chairman of the Board in place of Mr Thong Teong Bun. Mr Thong Teong Bun will retire from the Board at the upcoming General Meeting of the Company.Dr. Md Khussairiee Ahmad, (PhD, Computer Science) is a hands-on systems architect and has vast experience in the Information Technology systems development. He is currently working on artificial intelligent systems design and has deep knowledge in network...

口服紫杉醇和 Tirbanibulin 軟膏的監管進展順利持續推動口服紫杉醇商業化基礎設施和供應鏈宣佈進行兩項融資協議，總額高達 2.75 億美元2020 年產品銷售指南同比報告增長百分之十幾電話會議和現場網絡直播於今天上午 8:00（美國東部時間）舉行紐約洲水牛城, Aug. 07, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX) 是一家致力於研究、開發和商業化治療癌症和相關疾病新療法的的全球生物製藥公司。今天公佈截至 2020 年 6 月 30 日止的第二季度財務報表及業務摘要。Athenex 主席兼行政總裁 Johnson Lau 表示：「對 Athenex 來說，2020 年至今是成效很高的一年。我們持續在公司口服紫杉醇和 Tirbanibulin 軟膏這兩個主要產品中取得進步，而我們認為它們都是重要而有價值的藥物。我們正在改善公司的商業化基礎設施及供應鏈，進一步將 Athenex 定位為商業階段的生物製藥公司。我們也剛任命 Robert J. Spiegel 醫學博士加入董事會，他的經驗豐富，在開發和獲得腫瘤產品的批准方面經驗豐富。此外，我們透過獲取非稀釋性資本來加強資產負債表。此舉為我們提供財務靈活性，以便我們可以繼續推進主要候選藥物的開發和商業化，並進一步投資於口服紫杉醇的生命週期管理和其他產品開發活動。」 2020 年第二季度及近期業務重點：臨床項目：Tirbanibulin 軟膏用於光化性角化病 (AK)美國食品及藥物管理局 (FDA) 已為 tirbanibulin 軟膏的《處方藥使用者費用法》(PDUFA) 目標行動日期定為 2020 年 12 月 30 日。 公司的合作夥伴 Almirall 已向歐洲藥品管理局 (EMA) 提交營銷授權申請 (MAA)，更已通過驗證。口服紫杉醇用於治療轉移性乳腺癌Athenex 將在獲得 FDA 回覆後提供相關 NDA 提交的最新資訊。皮膚血管肉瘤中的口服紫杉醇...

HOUSTON, Aug. 07, 2020 (GLOBE NEWSWIRE) — Harvest Oil & Gas Corp. (OTCQX: HRST) (“Harvest” or the “Company”) announced today that it has declared a one-time cash distribution of $10.00 per share.The Board of Directors of Harvest has approved a one-time cash distribution of $10.00 per share to common stockholders of record on August 17, 2020 to be paid on August 24, 2020. The Company expects to have no current or accumulated earnings and profits (as determined for U.S. federal income tax purposes) and reasonably estimates that the cash distribution should not constitute a taxable dividend for U.S. federal income tax purposes. Rather, the cash distribution would generally first constitute non-taxable return of capital and a reduction in the adjusted tax basis (but not below zero) of each recipient stockholder’s shares of stock...

CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third quarter ended June 30, 2020.Third Quarter Fiscal 2020 Highlights:Consolidated Net Revenue of $84.8 million, up 75% year-over-yearLife Science segment delivers record revenue of $63.2 million, up 312% year-over-year, as a result of strong demand for COVID-19 related productsBroadened the Life Science portfolio of COVID-19 related products to include key reagents used by diagnostics manufacturers to develop rapid antigen testsDiagnostics segment limited to $21.6 million in revenue, in line with expectations and a 35% year-over-year decline, as stay-at-home orders reduced demand for non-critical care testingCompleted assay design lock in the development of a PCR COVID-19 test on the Revogene®...

ALLEN, Texas, Aug. 07, 2020 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, is reporting results for the second quarter ended June 30, 2020.Q2 2020 Highlights vs. Q2 2019Total revenues increased 20% to $82.4 million.Service fee equivalent (SFE) revenue (a non-GAAP measure defined and reconciled below) increased 23% to $62.3 million.Service fee gross margin was 34.2% compared to 34.8%.Net loss remained flat at $1.0 million or $(0.05) per share.Adjusted EBITDA (a non-GAAP measure defined and reconciled below) more than doubled to $7.2 million compared to $3.4 million.Management Commentary“Our business continues to benefit from heightened eCommerce demand in this new COVID-19 environment,” said Mike Willoughby, CEO of PFSweb. “We had a record second quarter for PFS fulfillment volumes, SFE revenue...

Sym3® Y tailored to critical conductor etch applications in 3D NAND, DRAM and foundry-logic nodesNewest offering broadens adoption of the fastest-ramping product in company historyMilestone reached: 5,000th Sym3 chamber has now shippedSANTA CLARA, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced a new addition to its highly successful Centris® Sym3® etch product family that now enables chipmakers to precisely pattern and shape ever-smaller features in leading-edge memory and logic chips.The new Centris Sym3® Y is Applied’s most advanced conductor etch system. It uses innovative RF pulsing technology to provide the extremely high materials selectivity, depth control and profile control needed by customers to create densely packed, high-aspect-ratio structures in 3D NAND, DRAM and logic, including FinFETs...

TORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) tillkännagav idag att andra kvartalets resultatrapport kommer att släppas efter marknadens stängning den 12 augusti 2020. Därefter kommer ett konferenssamtal att hållas med Dominic Duffy, President och Chief Executive Officer på Mandalay, för investerare och analytiker den 13 augusti 2020 klockan 8.00 (Tononto-tid).Analytiker och intresserade investerare inbjuds att delta genom att använda följande uppringningsnummer:En inspelning av konferenssamtalet kommer att finnas tillgänglig till kl. 11.59 (Toronto -tid), den 27 augusti 2020, och nås på följande uppringningsnummer:Mer information:Dominic DuffyPresident och Chief Executive OfficerEdison NguyenManager, Analytics och Investor RelationsKontakt:+1 647 260...

Second Quarter HighlightsAdjusted basic earnings per Class B share(3) of $0.59 down 14.5%; basic earnings per Class B share of $0.58 down 14.7%; currency translation nominalSales decreased 9.8% on 12.4% organic decline partially offset by 2.2% acquisition growth and 0.4% positive currency translationInnovia sales increased 21.4%, up 4.2% organicallyConsolidated operating income(1) down 17.7% on declines of 59.2% and 72.3% for Avery and Checkpoint, respectively; Innovia increased 78.2% and the CCL Segment declined 1.7%13.4% operating margin(1), down 130 bpsSix-Month HighlightsAdjusted basic earnings per Class B share(3) of $1.31 down 6.4%; basic earnings per Class B share of $1.29 down 6.5%; currency translation negative $0.01 per shareSales decreased 6.3% on the second quarter organic declines at Avery and CheckpointConsolidated operating...